Working… Menu

A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03967093
Recruitment Status : Recruiting
First Posted : May 30, 2019
Last Update Posted : July 17, 2019
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
Bexion Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : November 2020